Financial effect of converting ipratropium–albuterol therapy from inhalers to nebulizer treatments at an academic health system
Author:
Affiliation:
1. Department of Pharmacy, the Ohio State University Wexner Medical Center, Columbus, OH
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Pharmacology
Link
http://academic.oup.com/ajhp/article-pdf/73/3/121/28335691/ajhp0121.pdf
Reference7 articles.
1. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease;Levin;Am J Med,1996
2. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease;Gross;Respiration,1998
3. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology;Dolovich;Chest,2005
4. Aerogen. Top ten reasons to choose Aeroneb Solo. www.aerogen.com/products/aeroneb-solo/top-10-reasons.html (accessed 2015 Feb 23).
5. The causes and consequences of seasonal variation in COPD exacerbations;Donaldson;Int J Chron Obstruct Pulmon Dis,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Estimating Tiotropium Wasted Doses After Adding Revefenacin to an Inpatient Formulary: A Single-Center Cross-Sectional Study;Hospital Pharmacy;2024-01-04
2. Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) – A Systematic Review;International Journal of Chronic Obstructive Pulmonary Disease;2023-11
3. Choose Wisely: Metered Dose Inhalers Versus Nebulized Inhaled Solutions in The Inpatient Setting;Journal of Contemporary Pharmacy Practice;2021
4. Economic and workload impact of therapeutic interchange of inhaler medications and nebulizer solutions;American Journal of Health-System Pharmacy;2020-10-26
5. Economic impact and chronic obstructive pulmonary disease outcomes of a comprehensive inhaler to nebulization therapy protocol implementation in a large multi-state healthcare system;Current Medical Research and Opinion;2019-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3